Risk factors for emerging intraocular inflammation after intravitreal brolucizumab injection for age-related macular degeneration

PURPOSE: To analyze the risk factors associated with emerging intraocular inflammation (IOI) after intravitreal brolucizumab injection (IVBr) to treat age-related macular degeneration (AMD). METHODS: This study included 93 eyes of 90 patients. The incidence of emerging IOI was analyzed. The patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukai, Ryo, Matsumoto, Hidetaka, Akiyama, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648104/
https://www.ncbi.nlm.nih.gov/pubmed/34871313
http://dx.doi.org/10.1371/journal.pone.0259879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648104/
https://www.ncbi.nlm.nih.gov/pubmed/34871313
http://dx.doi.org/10.1371/journal.pone.0259879

Ejemplares similares